Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2023 Earnings Call Transcript May 10, 2023
Teva Pharmaceutical Industries Limited misses on earnings expectations. Reported EPS is $0.4 EPS, expectations were $0.56.
Operator: Hello, and welcome to the Q1 2023 Teva Pharmaceutical Industries Limited earnings conference call. My name is Alex. I’ll be coordinating the call today. [Operator instructions]. I’ll now hand over to your host, Ran Meir, SVP of Investor Relations. Please go...
